TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Wirgin Medicin och Konsult AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
132
|
143 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
-2
|
4 | |
| EBITDA |
-2
|
4 | |
| Total assets |
57
|
72 | |
| Current assets |
57
|
72 | |
| Current liabilities |
50
|
53 | |
| Equity capital |
7
|
19 | |
| - share capital |
4
|
5 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
12.3%
|
26.4% | |
| Turnover per employee |
66
|
72 | |
| Profit as a percentage of turnover |
-1.5%
|
2.8% | |
| Return on assets (ROA) |
-3.5%
|
5.6% | |
| Current ratio |
114.0%
|
135.8% | |
| Return on equity (ROE) |
-28.6%
|
21.1% | |
| Change turnover |
-6
|
-12 | |
| Change turnover % |
-2%
|
-4%
|
-8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.